Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “18F-HER2 PET”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Large-scale testing (Phase 3)Looking for participantsNCT06195709
What this trial is testing

ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer Patients

Who this might be right for
Breast Carcinoma
Institut Curie 300
Not applicableStudy completedNCT04992156
What this trial is testing

Prediction of 18F-FES-PET/CT Parameters on Palbociclib Combined With ET

Who this might be right for
Metastatic Breast Cancer
Fudan University 50
Not applicableStudy completedNCT01928186
What this trial is testing

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeMale Breast Carcinoma+7 more
University of Washington 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT02398773
What this trial is testing

FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy

Who this might be right for
HER2/Neu NegativeProgesterone Receptor NegativeProgesterone Receptor Positive+1 more
National Cancer Institute (NCI) 99
Not applicableUnknownNCT05983796
What this trial is testing

18F-HER2 PET in Evaluating the Efficacy of Anti-HER2 Therapy for Urothelial Carcinoma.

Who this might be right for
18F-HER2 PET
First Affiliated Hospital of Zhejiang University 100
Not applicableUnknownNCT04758416
What this trial is testing

Study on the Value of Non-invasive Dual-Pet Information in Subtype of Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Fudan University 50
Not applicableStudy completedNCT06655545
What this trial is testing

18F-fluoroestradiol (18F-FES) PET/CT Guided First-line Treatment for HR+/HER2- Metastatic Breast Cancer Patients

Who this might be right for
Breast Cancer
Fudan University 473
Post-approval studies (Phase 4)Active Not RecruitingNCT05486182
What this trial is testing

Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
GE Healthcare 153
Large-scale testing (Phase 3)UnknownNCT05861830
What this trial is testing

Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES)

Who this might be right for
Advanced Breast Cancer
Peking Union Medical College Hospital 80
Not applicableLooking for participantsNCT06708910
What this trial is testing

AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI

Who this might be right for
HER2 Positive Breast Carcinoma
Heinrich-Heine University, Duesseldorf 460
Not applicableLooking for participantsNCT06916637
What this trial is testing

Clinical Study on the Application of 18F-HER2 Affibody PET Imaging in HER2-Expressing Breast Cancer

Who this might be right for
Breast CancerBreast Cancer, HER2-Expression
The Affiliated Hospital of Qingdao University 40
Testing effectiveness (Phase 2)Study completedNCT02599194
What this trial is testing

18F-FSPG PET/CT for Cancer Patients on Therapy

Who this might be right for
B-Cell NeoplasmEstrogen Receptor NegativeHER2/Neu Negative+13 more
Andrei Iagaru 7
Testing effectiveness (Phase 2)Looking for participantsNCT04573231
What this trial is testing

Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Who this might be right for
Breast CancerHER2-negative Breast CancerMetastatic Breast Cancer
University of Wisconsin, Madison 13
Testing effectiveness (Phase 2)Looking for participantsNCT07471776
What this trial is testing

Study on Using TROP2-PET and 18F-FDG PET to Predict the Efficacy of Anti TROP2 ADC Treatment in Advanced Breast Cancer

Who this might be right for
Metastatic Breast Cancer ( HER2 Negative)
Fudan University 45
Not applicableLooking for participantsNCT03827317
What this trial is testing

HERPET- A Novel PET Imaging Study of HER2 in Breast Cancer

Who this might be right for
Breast Cancer
Imperial College London 24
Not applicableUnknownNCT05165602
What this trial is testing

Evaluation of HER2-targeted Therapy for Gastric Cancer and Establishment and Verification of Monitoring System

Who this might be right for
HER2 Positive Gastric Cancer
Peking University 30
Not applicableNot Yet RecruitingNCT07130344
What this trial is testing

PERCIST Evaluation of Trastuzumab Deruxtecan in the Treatment of HER2 Low Breast Cancer

Who this might be right for
Metastatic Breast CancerHER 2 Low-expressing Breast Cancer
Centre Paul Strauss 262